Cytori, Astellas Pharma sign strategic equity agreement
Astellas will purchase approximately 1.43 million unregistered shares of Cytori common stock at $7 per share for net proceeds to Cytori of $10m. As part of the agreement,
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.
The report, titled ‘Targeting Emerging Delivery Technologies across the Value Chain: From Chemicals and Materials Suppliers to End-Products and Applications,’ applies the Lux Innovation Grid framework to evaluate
The new analysis ‘Strategic Analysis of Russian Pharmaceutical Market’ found that the market will reach $37.15bn in 2016. The Russian government initiative 2020 Pharmaceutical Development Programme (Pharma 2020)
The Pennsylvania facility has been engaged primarily in contract manufacturing of molded plastic components and assemblies for consumer-product applications. The Cornwall facility produces molded elastomeric components for disposable